ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver Cancer Treatment Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-35S12395
Home | Market Reports | Health| Health Conditions| Cancer
Global Liver Cancer Treatment Drug Market Research Report 2022
BUY CHAPTERS

Global Liver Cancer Treatment Drug Market Research Report 2025

Code: QYRE-Auto-35S12395
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
4SC AG
Alnylam Pharmaceuticals Inc
AVEO Pharmaceuticals Inc
Bayer
Bristol-Myers Squibb Co
Celsion Corp
Dicerna Pharmaceuticals Inc
Eli Lilly and Co
Exelixis Inc
F Hoffmann La Roche Ltd
FibroGen Inc
Novartis International AG
Pfizer Inc
Thermo Fisher Scientific Inc
General Electric Co.(GE Healthcare)
Merck & Co., Inc.(ArQule, Inc.)
Nymox Corp.
SMC Laboratories, Inc.
Becton, Dickinson and Co.

Liver Cancer Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liver Cancer Treatment Drug Market

Liver Cancer Treatment Drug Market

The global market for Liver Cancer Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Treatment Drug.
The Liver Cancer Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Cancer Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liver Cancer Treatment Drug Market Report

Report Metric Details
Report Name Liver Cancer Treatment Drug Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG, Becton, Dickinson and Co., Bristol-Myers Squibb Co., Celsion Corp., Dicerna Pharmaceuticals, Inc., Eli Lilly and Co., Exelixis, Inc., F. Hoffmann-La Roche, Ltd., FibroGen, Inc., General Electric Co.(GE Healthcare), Merck & Co., Inc.(ArQule, Inc.), Novartis International AG, Nymox Corp., Pfizer, Inc., SMC Laboratories, Inc., Thermo Fisher Scientific, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liver Cancer Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liver Cancer Treatment Drug Market report?

Ans: The main players in the Liver Cancer Treatment Drug Market are 4SC AG, Alnylam Pharmaceuticals, Inc., AVEO Pharmaceuticals, Inc, Bayer AG, Becton, Dickinson and Co., Bristol-Myers Squibb Co., Celsion Corp., Dicerna Pharmaceuticals, Inc., Eli Lilly and Co., Exelixis, Inc., F. Hoffmann-La Roche, Ltd., FibroGen, Inc., General Electric Co.(GE Healthcare), Merck & Co., Inc.(ArQule, Inc.), Novartis International AG, Nymox Corp., Pfizer, Inc., SMC Laboratories, Inc., Thermo Fisher Scientific, Inc.

What are the Application segmentation covered in the Liver Cancer Treatment Drug Market report?

Ans: The Applications covered in the Liver Cancer Treatment Drug Market report are Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Other

What are the Type segmentation covered in the Liver Cancer Treatment Drug Market report?

Ans: The Types covered in the Liver Cancer Treatment Drug Market report are Targeted Therapy, Radiation Therapy, Immunotherapy, Chemotherapy, Other

Recommended Reports

Cancer Treatment Drugs

Cancer Immunotherapy

Liver & Biliary Cancer

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Therapy
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Chemotherapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Liver Cancer Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hepatocellular Carcinoma
1.3.3 Cholangio Carcinoma
1.3.4 Hepatoblastoma
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Cancer Treatment Drug Market Perspective (2020-2031)
2.2 Global Liver Cancer Treatment Drug Growth Trends by Region
2.2.1 Global Liver Cancer Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liver Cancer Treatment Drug Historic Market Size by Region (2020-2025)
2.2.3 Liver Cancer Treatment Drug Forecasted Market Size by Region (2026-2031)
2.3 Liver Cancer Treatment Drug Market Dynamics
2.3.1 Liver Cancer Treatment Drug Industry Trends
2.3.2 Liver Cancer Treatment Drug Market Drivers
2.3.3 Liver Cancer Treatment Drug Market Challenges
2.3.4 Liver Cancer Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Cancer Treatment Drug Players by Revenue
3.1.1 Global Top Liver Cancer Treatment Drug Players by Revenue (2020-2025)
3.1.2 Global Liver Cancer Treatment Drug Revenue Market Share by Players (2020-2025)
3.2 Global Liver Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liver Cancer Treatment Drug Revenue
3.4 Global Liver Cancer Treatment Drug Market Concentration Ratio
3.4.1 Global Liver Cancer Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Treatment Drug Revenue in 2024
3.5 Global Key Players of Liver Cancer Treatment Drug Head office and Area Served
3.6 Global Key Players of Liver Cancer Treatment Drug, Product and Application
3.7 Global Key Players of Liver Cancer Treatment Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Cancer Treatment Drug Breakdown Data by Type
4.1 Global Liver Cancer Treatment Drug Historic Market Size by Type (2020-2025)
4.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2026-2031)
5 Liver Cancer Treatment Drug Breakdown Data by Application
5.1 Global Liver Cancer Treatment Drug Historic Market Size by Application (2020-2025)
5.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liver Cancer Treatment Drug Market Size (2020-2031)
6.2 North America Liver Cancer Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liver Cancer Treatment Drug Market Size by Country (2020-2025)
6.4 North America Liver Cancer Treatment Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Cancer Treatment Drug Market Size (2020-2031)
7.2 Europe Liver Cancer Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liver Cancer Treatment Drug Market Size by Country (2020-2025)
7.4 Europe Liver Cancer Treatment Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Cancer Treatment Drug Market Size (2020-2031)
8.2 Asia-Pacific Liver Cancer Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Cancer Treatment Drug Market Size (2020-2031)
9.2 Latin America Liver Cancer Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liver Cancer Treatment Drug Market Size by Country (2020-2025)
9.4 Latin America Liver Cancer Treatment Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Cancer Treatment Drug Market Size (2020-2031)
10.2 Middle East & Africa Liver Cancer Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4SC AG
11.1.1 4SC AG Company Details
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Liver Cancer Treatment Drug Introduction
11.1.4 4SC AG Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.1.5 4SC AG Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 AVEO Pharmaceuticals, Inc
11.3.1 AVEO Pharmaceuticals, Inc Company Details
11.3.2 AVEO Pharmaceuticals, Inc Business Overview
11.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Introduction
11.3.4 AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.3.5 AVEO Pharmaceuticals, Inc Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Liver Cancer Treatment Drug Introduction
11.4.4 Bayer AG Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.4.5 Bayer AG Recent Development
11.5 Becton, Dickinson and Co.
11.5.1 Becton, Dickinson and Co. Company Details
11.5.2 Becton, Dickinson and Co. Business Overview
11.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Introduction
11.5.4 Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.5.5 Becton, Dickinson and Co. Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Details
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Introduction
11.6.4 Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 Celsion Corp.
11.7.1 Celsion Corp. Company Details
11.7.2 Celsion Corp. Business Overview
11.7.3 Celsion Corp. Liver Cancer Treatment Drug Introduction
11.7.4 Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.7.5 Celsion Corp. Recent Development
11.8 Dicerna Pharmaceuticals, Inc.
11.8.1 Dicerna Pharmaceuticals, Inc. Company Details
11.8.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.8.4 Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.8.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.9 Eli Lilly and Co.
11.9.1 Eli Lilly and Co. Company Details
11.9.2 Eli Lilly and Co. Business Overview
11.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Introduction
11.9.4 Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.9.5 Eli Lilly and Co. Recent Development
11.10 Exelixis, Inc.
11.10.1 Exelixis, Inc. Company Details
11.10.2 Exelixis, Inc. Business Overview
11.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Introduction
11.10.4 Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.10.5 Exelixis, Inc. Recent Development
11.11 F. Hoffmann-La Roche, Ltd.
11.11.1 F. Hoffmann-La Roche, Ltd. Company Details
11.11.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Introduction
11.11.4 F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.11.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Details
11.12.2 FibroGen, Inc. Business Overview
11.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Introduction
11.12.4 FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.12.5 FibroGen, Inc. Recent Development
11.13 General Electric Co.(GE Healthcare)
11.13.1 General Electric Co.(GE Healthcare) Company Details
11.13.2 General Electric Co.(GE Healthcare) Business Overview
11.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Introduction
11.13.4 General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.13.5 General Electric Co.(GE Healthcare) Recent Development
11.14 Merck & Co., Inc.(ArQule, Inc.)
11.14.1 Merck & Co., Inc.(ArQule, Inc.) Company Details
11.14.2 Merck & Co., Inc.(ArQule, Inc.) Business Overview
11.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Introduction
11.14.4 Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.14.5 Merck & Co., Inc.(ArQule, Inc.) Recent Development
11.15 Novartis International AG
11.15.1 Novartis International AG Company Details
11.15.2 Novartis International AG Business Overview
11.15.3 Novartis International AG Liver Cancer Treatment Drug Introduction
11.15.4 Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.15.5 Novartis International AG Recent Development
11.16 Nymox Corp.
11.16.1 Nymox Corp. Company Details
11.16.2 Nymox Corp. Business Overview
11.16.3 Nymox Corp. Liver Cancer Treatment Drug Introduction
11.16.4 Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.16.5 Nymox Corp. Recent Development
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Details
11.17.2 Pfizer, Inc. Business Overview
11.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Introduction
11.17.4 Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.17.5 Pfizer, Inc. Recent Development
11.18 SMC Laboratories, Inc.
11.18.1 SMC Laboratories, Inc. Company Details
11.18.2 SMC Laboratories, Inc. Business Overview
11.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Introduction
11.18.4 SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.18.5 SMC Laboratories, Inc. Recent Development
11.19 Thermo Fisher Scientific, Inc.
11.19.1 Thermo Fisher Scientific, Inc. Company Details
11.19.2 Thermo Fisher Scientific, Inc. Business Overview
11.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Introduction
11.19.4 Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025)
11.19.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
4SC AG
Alnylam Pharmaceuticals Inc
AVEO Pharmaceuticals Inc
Bayer
Bristol-Myers Squibb Co
Celsion Corp
Dicerna Pharmaceuticals Inc
Eli Lilly and Co
Exelixis Inc
F Hoffmann La Roche Ltd
FibroGen Inc
Novartis International AG
Pfizer Inc
Thermo Fisher Scientific Inc
General Electric Co.(GE Healthcare)
Merck & Co., Inc.(ArQule, Inc.)
Nymox Corp.
SMC Laboratories, Inc.
Becton, Dickinson and Co.
List of Tables
 Table 1. Global Liver Cancer Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Targeted Therapy
 Table 3. Key Players of Radiation Therapy
 Table 4. Key Players of Immunotherapy
 Table 5. Key Players of Chemotherapy
 Table 6. Key Players of Other
 Table 7. Global Liver Cancer Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Liver Cancer Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Liver Cancer Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Liver Cancer Treatment Drug Market Share by Region (2020-2025)
 Table 11. Global Liver Cancer Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Liver Cancer Treatment Drug Market Share by Region (2026-2031)
 Table 13. Liver Cancer Treatment Drug Market Trends
 Table 14. Liver Cancer Treatment Drug Market Drivers
 Table 15. Liver Cancer Treatment Drug Market Challenges
 Table 16. Liver Cancer Treatment Drug Market Restraints
 Table 17. Global Liver Cancer Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Liver Cancer Treatment Drug Market Share by Players (2020-2025)
 Table 19. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2024)
 Table 20. Ranking of Global Top Liver Cancer Treatment Drug Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Liver Cancer Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Liver Cancer Treatment Drug, Headquarters and Area Served
 Table 23. Global Key Players of Liver Cancer Treatment Drug, Product and Application
 Table 24. Global Key Players of Liver Cancer Treatment Drug, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Liver Cancer Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2020-2025)
 Table 28. Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2026-2031)
 Table 30. Global Liver Cancer Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2020-2025)
 Table 32. Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2026-2031)
 Table 34. North America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Liver Cancer Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Liver Cancer Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Liver Cancer Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Liver Cancer Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Liver Cancer Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Liver Cancer Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Liver Cancer Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 49. 4SC AG Company Details
 Table 50. 4SC AG Business Overview
 Table 51. 4SC AG Liver Cancer Treatment Drug Product
 Table 52. 4SC AG Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 53. 4SC AG Recent Development
 Table 54. Alnylam Pharmaceuticals, Inc. Company Details
 Table 55. Alnylam Pharmaceuticals, Inc. Business Overview
 Table 56. Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
 Table 57. Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 58. Alnylam Pharmaceuticals, Inc. Recent Development
 Table 59. AVEO Pharmaceuticals, Inc Company Details
 Table 60. AVEO Pharmaceuticals, Inc Business Overview
 Table 61. AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product
 Table 62. AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 63. AVEO Pharmaceuticals, Inc Recent Development
 Table 64. Bayer AG Company Details
 Table 65. Bayer AG Business Overview
 Table 66. Bayer AG Liver Cancer Treatment Drug Product
 Table 67. Bayer AG Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 68. Bayer AG Recent Development
 Table 69. Becton, Dickinson and Co. Company Details
 Table 70. Becton, Dickinson and Co. Business Overview
 Table 71. Becton, Dickinson and Co. Liver Cancer Treatment Drug Product
 Table 72. Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 73. Becton, Dickinson and Co. Recent Development
 Table 74. Bristol-Myers Squibb Co. Company Details
 Table 75. Bristol-Myers Squibb Co. Business Overview
 Table 76. Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product
 Table 77. Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 78. Bristol-Myers Squibb Co. Recent Development
 Table 79. Celsion Corp. Company Details
 Table 80. Celsion Corp. Business Overview
 Table 81. Celsion Corp. Liver Cancer Treatment Drug Product
 Table 82. Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 83. Celsion Corp. Recent Development
 Table 84. Dicerna Pharmaceuticals, Inc. Company Details
 Table 85. Dicerna Pharmaceuticals, Inc. Business Overview
 Table 86. Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
 Table 87. Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 88. Dicerna Pharmaceuticals, Inc. Recent Development
 Table 89. Eli Lilly and Co. Company Details
 Table 90. Eli Lilly and Co. Business Overview
 Table 91. Eli Lilly and Co. Liver Cancer Treatment Drug Product
 Table 92. Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 93. Eli Lilly and Co. Recent Development
 Table 94. Exelixis, Inc. Company Details
 Table 95. Exelixis, Inc. Business Overview
 Table 96. Exelixis, Inc. Liver Cancer Treatment Drug Product
 Table 97. Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 98. Exelixis, Inc. Recent Development
 Table 99. F. Hoffmann-La Roche, Ltd. Company Details
 Table 100. F. Hoffmann-La Roche, Ltd. Business Overview
 Table 101. F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product
 Table 102. F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 103. F. Hoffmann-La Roche, Ltd. Recent Development
 Table 104. FibroGen, Inc. Company Details
 Table 105. FibroGen, Inc. Business Overview
 Table 106. FibroGen, Inc. Liver Cancer Treatment Drug Product
 Table 107. FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 108. FibroGen, Inc. Recent Development
 Table 109. General Electric Co.(GE Healthcare) Company Details
 Table 110. General Electric Co.(GE Healthcare) Business Overview
 Table 111. General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product
 Table 112. General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 113. General Electric Co.(GE Healthcare) Recent Development
 Table 114. Merck & Co., Inc.(ArQule, Inc.) Company Details
 Table 115. Merck & Co., Inc.(ArQule, Inc.) Business Overview
 Table 116. Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product
 Table 117. Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 118. Merck & Co., Inc.(ArQule, Inc.) Recent Development
 Table 119. Novartis International AG Company Details
 Table 120. Novartis International AG Business Overview
 Table 121. Novartis International AG Liver Cancer Treatment Drug Product
 Table 122. Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 123. Novartis International AG Recent Development
 Table 124. Nymox Corp. Company Details
 Table 125. Nymox Corp. Business Overview
 Table 126. Nymox Corp. Liver Cancer Treatment Drug Product
 Table 127. Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 128. Nymox Corp. Recent Development
 Table 129. Pfizer, Inc. Company Details
 Table 130. Pfizer, Inc. Business Overview
 Table 131. Pfizer, Inc. Liver Cancer Treatment Drug Product
 Table 132. Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 133. Pfizer, Inc. Recent Development
 Table 134. SMC Laboratories, Inc. Company Details
 Table 135. SMC Laboratories, Inc. Business Overview
 Table 136. SMC Laboratories, Inc. Liver Cancer Treatment Drug Product
 Table 137. SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 138. SMC Laboratories, Inc. Recent Development
 Table 139. Thermo Fisher Scientific, Inc. Company Details
 Table 140. Thermo Fisher Scientific, Inc. Business Overview
 Table 141. Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product
 Table 142. Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2020-2025) & (US$ Million)
 Table 143. Thermo Fisher Scientific, Inc. Recent Development
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Liver Cancer Treatment Drug Picture
 Figure 2. Global Liver Cancer Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liver Cancer Treatment Drug Market Share by Type: 2024 VS 2031
 Figure 4. Targeted Therapy Features
 Figure 5. Radiation Therapy Features
 Figure 6. Immunotherapy Features
 Figure 7. Chemotherapy Features
 Figure 8. Other Features
 Figure 9. Global Liver Cancer Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Liver Cancer Treatment Drug Market Share by Application: 2024 VS 2031
 Figure 11. Hepatocellular Carcinoma Case Studies
 Figure 12. Cholangio Carcinoma Case Studies
 Figure 13. Hepatoblastoma Case Studies
 Figure 14. Other Case Studies
 Figure 15. Liver Cancer Treatment Drug Report Years Considered
 Figure 16. Global Liver Cancer Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Liver Cancer Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Liver Cancer Treatment Drug Market Share by Region: 2024 VS 2031
 Figure 19. Global Liver Cancer Treatment Drug Market Share by Players in 2024
 Figure 20. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Liver Cancer Treatment Drug Revenue in 2024
 Figure 22. North America Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Liver Cancer Treatment Drug Market Share by Country (2020-2031)
 Figure 24. United States Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Liver Cancer Treatment Drug Market Share by Country (2020-2031)
 Figure 28. Germany Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Liver Cancer Treatment Drug Market Share by Region (2020-2031)
 Figure 36. China Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Liver Cancer Treatment Drug Market Share by Country (2020-2031)
 Figure 44. Mexico Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Liver Cancer Treatment Drug Market Share by Country (2020-2031)
 Figure 48. Turkey Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Liver Cancer Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. 4SC AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 52. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 53. AVEO Pharmaceuticals, Inc Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 54. Bayer AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 55. Becton, Dickinson and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 56. Bristol-Myers Squibb Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 57. Celsion Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 58. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 59. Eli Lilly and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 60. Exelixis, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 61. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 62. FibroGen, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 63. General Electric Co.(GE Healthcare) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 64. Merck & Co., Inc.(ArQule, Inc.) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 65. Novartis International AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 66. Nymox Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 67. Pfizer, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 68. SMC Laboratories, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 69. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis C Virus Drugs Market Research Report 2025
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Adult Chronic Hepatitis B Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cirrhosis Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Failure Therapeutics Market Research Report 2025
Global Unresectable Hepatocellular Carcinoma Treatment Market Research Report 2024
Global Alcoholic Hepatiti Drug Market Research Report 2024
Chronic Liver Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncolytic Virus Drug Treatment Market Research Report 2025
Global Gallbladder Cancer Treatment Market Research Report 2024
Global Intratumoral Cancer Therapies Market Research Report 2025
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions